Portola Valley, CA, United States of America

Jane S Lebkowski

This inventor holds 20 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 2 EPO patents, primarily in Stem Cell Research. Top assignees: Rhone-Poulenc Rorer Pharmaceuticals Inc., Asterias Biotherapeutics, Inc., Applied Immunesciences, Inc.. Active years: 1992-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jane S Lebkowski. Retrieved from https://idiyas.com/inventor/jane-s-lebkowski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 20 (Patent Applications = 5)

% Patents Active = 80.0

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 2.5

ph-index = 10

Forward Citations = 769(Granted Patents)

Company Filing History:

6 out of 111

Rhone-Poulenc Rorer Pharmaceuticals Inc.

patents

5 out of 23

Asterias Biotherapeutics, Inc.

patents

4 out of 17

Applied Immunesciences, Inc.

Aventis Pharmaceuticals Inc.

patents

6. 1 out of 2,376

Regents of the University of Minnesota

patents

where one patent can have more than one assignee

Years Active: 1992-2021

Loading Chart...

Areas of Expertise:

Pluripotent Stem Cells

Oligodendrocyte Progenitor Cells

Hematopoietic Lineage

Differentiation

Adeno-Associated Viral Vectors

Transfection

Cell Population

Stem Cell Treatment

Immune Stimulation

Recombinant Vectors

Cell Progeny

In Vitro Differentiation

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11123374 - Pluripotent stem cell-derived oligodendrocyte progenitor cells for the treatment of spinal cord injury (2021-09-21),

2. 10344262 - Differentiation of primate pluripotent stem cells to hematopoietic lineage cells (2019-07-09),

3. 10286009 - Pluripotent stem cell-derived oligodendrocyte progenitor cells for the treatment of spinal cord injury (2019-05-14),

4. 9074182 - Differentiated pluripotent stem cell progeny depleted of extraneous phenotypes (2015-07-07),

5. 9023645 - Isolated in vitro cell population comprising primate pluripotent stem cells containing a nucleic acid construct and differentiated progeny of the pluripotent stem cells (2015-05-05),

6. 8426198 - In vitro differentiated cell and human embryonic stem cell population (2013-04-23),

7. 8323966 - Differentiated pluripotent stem cell progeny depleted of extraneous phenotypes (2012-12-04),

8. 8093049 - Differentiation of primate pluripotent stem cells to hematopoietic lineage cells (2012-01-10),

9. 6652850 - Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity (2003-11-25),

10. 6576464 - Methods for providing differentiated stem cells (2003-06-10),

11. 5861314 - Adeno-associated viral (AAV) liposomes and methods related thereto (1999-01-19),

12. 5861171 - Adeno-associated viral (AAV) liposomes and methods related thereto (1999-01-19),

13. 5834441 - Adeno-associated viral (AAV) liposomes and methods related thereto (1998-11-10),

14. 5807686 - Pluripotential quiescent stem cell population (1998-09-15),

15. 5780280 - Recombinant adeno-associated virus vectors (1998-07-14),

Title: The Innovative Journey of Jane S Lebkowski

Introduction: Jane S Lebkowski is a pioneering inventor based in Portola Valley, California. Her groundbreaking work in the field of biotechnology has led to numerous patents and advancements in the medical industry.

Latest Patents: Jane S Lebkowski holds several patents related to stem cell research and regenerative medicine, showcasing her commitment to pushing the boundaries of scientific discovery.

Career Highlights: With a career spanning several decades, Jane S Lebkowski has held key positions in various biotech companies, contributing significantly to the development of cutting-edge therapies and treatments. Her expertise in molecular biology and cell therapy has been instrumental in shaping the future of healthcare.

Collaborations: Throughout her career, Jane S Lebkowski has collaborated with leading researchers, scientists, and medical professionals to further the field of regenerative medicine. Her collaborative spirit and innovative approach have resulted in groundbreaking discoveries that have the potential to revolutionize the medical landscape.

Conclusion: Jane S Lebkowski's dedication to innovation and her relentless pursuit of scientific excellence have cemented her reputation as a trailblazer in the field of biotechnology. Her work continues to inspire future generations of inventors and researchers to push the boundaries of what is possible in the world of medical science.

Profile summary based on public USPTO records.